Nasus Pharma

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$0-$9.99
Market Cap
$36.8M
Shares Short
64,912

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
-$0.72

News

See more

Yahoo Finance • 10 days ago

Nasus Pharma to Participate in Upcoming Investor Conferences

Yahoo Finance • 2 months ago

Nasus Pharma Advances NS002 Towards Pivotal Study Following Positive Phase 2; Reports Annual Results and Provides Business Update

Yahoo Finance • 2 months ago

BriefCast Publishes Transcript: Nasus Pharma NS002 Phase 2 Positive Topline Results Webinar Transcript

Yahoo Finance • 2 months ago

Nasus Pharma Announces Positive Top Line Data from Phase 2 Clinical Study of NS002: Achieves Significantly Superior and Faster Epinephrine Delivery Compared to EpiPen® with Accelerated Speed to Therapeutic Threshold

About

CEO
Mr. Dan Teleman MBA M.Sc.
CFO
Mr. Eyal Rubin M.B.A.
Address
Yigal Alon 65, Tel Aviv-Yafo, Israel, 6744317
Sector
Healthcare
Industry
Drug Manufacturers - General
Full-Time Employees
7